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In the current internet era, with easy and rapid access to
medical information on our smart-phones, one might question the
relevance of medical textbooks. Yet, then comes along something
that reminds me of the power of a book, one that is highly
readable and provides me with that old-fashioned tactile pleasure.
I admit it; I prefer to read off of paper to a screen. I had the recent
pleasure of reading the newly published ERS Monograph on
Cystic Fibrosis, edited by Marcus A. Mall and J. Stuart Elborn, a
timely and comprehensive update of a similar monograph
published in 2006. It was a gift that I read on my return home
from the European CF meeting this summer. This was no dull
tome with properties of sleep induction, but was engaging and
enlightening, a reminder that I still have a lot to learn. The book is
concise but rather comprehensive, and well-written. It offers a
great deal to the experienced CF clinician and scientist, but is not
so dense that it can also be recommended for the novice. The
topics covered are rather complete, ranging from basic science,
such as the pathophysiology of lung disease, to purely clinical
research, such as identifying endpoints and biomarkers for
clinical trials. The presentation of data and hypotheses is
extremely well-balanced, so we should thank the authors for
their clarity of writing as well as the editors for their steady
guidance.http://dx.doi.org/10.1016/j.jcf.2014.11.003
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most recent of observations. Some of these highlights of
advances include what has been learned from the development
of novel animal models, namely the CF pig model and the EnaC
mouse model, as well as the exploding field of the microbiome.
The investigation of genetics is supposed to make our
understanding of CF all the more clear, but I admit that I seem
to get more confused as I learn more; the chapters on genetic
modifiers of CF and newborn screening have brought some
perspective back. Translation of these findings from basic to
clinical science is well covered and some of the challenges still to
be faced are outlined.
Although the book is mostly invested in pulmonary disease
and complications, there is ample coverage of extra-pulmonary
manifestations of CF. Social issues are reviewed, such as the
transition of the patient from a pediatric to an adult care system,
as well as the complex issues faced by the adult with CF. What
I found most appealing about this monograph is its inclusivity,
engaging authors worldwide including Europe, the United
States, Canada, and Australia. It is also highly collaborative
with many chapters written by a group of authors representing
several countries.
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